Skip to search formSkip to main contentSkip to account menu

MDL 72145

Known as: MDL-72145 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Summary1.The pharmacological properties of two selective inhibitors of monoamine oxidase (MAO) type B,l-deprenyl and MDL 72145… 
Highly Cited
1999
Highly Cited
1999
The endogenous substrate(s) and physiological function(s) of semicarbazide-sensitive amine oxidase (SSAO), a group of enzymes… 
1989
1989
Abstract— One hour after MDL 72145 ((E)‐2‐(3′,4′‐dimethoxyphenyl)‐3‐fluoroallylamine) (2·5 mg kg−1) was given by intraperitoneal… 
1989
1989
1 The pressor response to the infusion of tyramine (Tyr) into the isolated perfused mesenteric arterial bed of the rat has been… 
Highly Cited
1987
Highly Cited
1987
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP) was shown previously to be a more potent neurotoxicant than… 
1985
1985
(E)‐2‐(3, 4‐dimethoxyphenyl)‐3‐fluoroallylamine (MDL 72145) was found to be an extremely potent inhibitor of the semicarbazide…